Investing

Bausch & Lomb’s stock soars 9% after earnings beat

Bausch & Lomb Corp.’s stock soared 10% early Wednesday after the eye-care company reported adjusted fourth-quarter profit that topped estimates and offered upbeat revenue guidance

News Room News Room 3 Min Read

Your best advisor to finance and money management.

Explaining Finance is your one-stop website for the latest news, updates, and tips about finance.

Latest News

Here’s what’s new on Hulu in November 2023 — and what’s leaving

Hulu has a loaded lineup in November 2023, with a pair of highly anticipated FX dramas, an epic Baz Luhrmann

News Room News Room

Opinion: ‘Revenge travel’ is over. Shoppers are spending on goods again and these 3 retailers could benefit.

With summer travel season winding down and holiday gift-giving season ahead, consumers are shifting their spending to goods from services.

News Room News Room

‘Jeopardy!’ host and champ Ken Jennings reveals the ‘secret sauce’ to winning

“‘Often the margin of victory is just reflexes.’” — Ken Jennings That’s “Jeopardy!” champion-turned-host Ken Jennings, revealing the secret to

News Room News Room

How likely is a 1987-style stock-market crash today? Likelier than you’d think.

Thirty-six years ago, on Oct. 19, 1987, the U.S. stock market suffered its worst crash ever. That day, the Dow

News Room News Room

Here’s what the Israel-Hamas war has done to U.S. gasoline and diesel prices

Fuel prices, with the cost of gasoline and diesel at the pump both down from a month ago, don’t appear

News Room News Room

Oil scores back-to-back weekly gains as Israel-Hamas war raises risks in the Middle East

Oil futures settled with a loss on Friday, but scored a second straight weekly gain after the Oct. 7 attack

News Room News Room

Bausch Health Gets FDA Approval for Acne Treatment Cabtreo

By Ben Glickman Bausch Health Cos. has received approval from the Food and Drug Administration for Cabtreo, its topical gel

News Room News Room

Akumin Shares Rise 41% on Deal to Go Private

By Ben Glickman Shares of Akumin rose Friday after the company said it had agreed to be taken private by

News Room News Room

SCWorx Agrees to Acquire American Energy Partners

By Stephen Nakrosis SCWorx said on Friday it entered into a letter of intent to acquire American Energy Partners, an

News Room News Room

Troika Media Issues Going Concern Warning

By Josh Beckerman Troika Media Group said there is substantial doubt about its ability to continue as a going concern

News Room News Room

Stocks to Watch: Great Ajax, Akumin, BioMarin Pharmaceutical

By Ben Glickman Great Ajax Corp. said it wouldn't be acquired by Ellington Financial after the two real-estate investment trusts

News Room News Room

Why Chip Makers Favor Arizona

To the Editor:Along with Taiwan Semiconductor Manufacturing’s $40 billion investment in Arizona, Intel is investing $20 billion in expanding its

News Room News Room

Blue Apron, E2open, and More Stocks See Action From Activist Investors

These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an

News Room News Room

VMware Holders Face Key Deadline on Monday for Broadcom Merger

VMware stock was up Friday at $150.91, while Broadcom was off 1.6% at $853.63. Gabby Jones/Bloomberg VMware investors have a

News Room News Room

Amazon Stock Could Climb More Than 35%, Wedbush Says

Uncredited These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a

News Room News Room

Comerica profit drops by 28% but beats Wall Street estimate

Comerica Inc.’s stock dropped nearly 7% on Friday after it missed analyst estimates for core deposits and loans, although its

News Room News Room

Opinion: Biotech stocks are in a post-pandemic slump and recovery in 2024 is questionable

Novavax NVAX, +5.24% stands out as a stark reminder of the biotech sector’s faltering steps in 2023. Once renowned for

News Room News Room

Bond investors are missing this silver lining from higher interest rates

Might fixed-income investors be better off because of the worst bear market in history? It seems ludicrous to even ask.

News Room News Room